BUZZ-GoodRX appoints Wendy Barnes as CEO; shares rise

Reuters12-17

** GoodRX shares rise 1.3% to $4.65 after the bell

** Co appoints Wendy Barnes as president and chief executive officer effective January 1, 2025

** Barnes previously held the position of CEO at RxBenefits

** As CEO, Wendy will focus on bringing all brand affordability programs onto the GoodRx platform, expanding GoodRx's product experience with healthcare professionals and enriching partnerships with retail pharmacies, insurers and pharmaceutical manufacturers - GDRX

** Barnes replaces Scott Wagner, who was the interim CEO at the company, appointed in April 2023

** 9 of 18 brokerages rate the stock "buy" or higher, 8 "hold" and 1 "sell"; their median PT is $7

** YTD, GDRX down 31.4%

(Reporting by Abhinav Parmar in Bengaluru)

((Abhinav.parmar@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2492280556?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-12-17 05:32","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2492280556","market":"us","top_or_hot":-1,"title":"BUZZ-GoodRX appoints Wendy Barnes as CEO; shares rise","media":"Reuters","content":"<html><body><p>** GoodRX    shares rise 1.3% to $4.65 after the bell</p><p>   ** Co appoints Wendy Barnes as president and chief executive officer effective January 1, 2025</p><p>   ** Barnes previously held the position of CEO at RxBenefits </p><p>   ** As CEO, Wendy will focus on bringing all brand affordability programs onto the GoodRx platform, expanding GoodRx's product experience with healthcare professionals and enriching partnerships with retail pharmacies, insurers and pharmaceutical manufacturers - GDRX</p><p>   ** Barnes replaces Scott Wagner, who was the interim CEO at the company, appointed in April 2023</p><p>   ** 9 of 18 brokerages rate the stock \"buy\" or higher, 8 \"hold\" and 1 \"sell\"; their median PT is $7</p><p>   ** YTD, GDRX down 31.4%</p><p> (Reporting by Abhinav Parmar in Bengaluru)</p><p>((Abhinav.parmar@thomsonreuters.com))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BUZZ-GoodRX appoints Wendy Barnes as CEO; shares rise</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBUZZ-GoodRX appoints Wendy Barnes as CEO; shares rise\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-12-17 05:32 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>** GoodRX    shares rise 1.3% to $4.65 after the bell   ** Co appoints Wendy Barnes as president and chief executive officer effective January 1, 2025   ** Barnes previously held the position of CEO ...</p>\n\n<a href=\"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4161","symbol_name":"工业机械","start_time":0,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2492280556","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2492280556","pubTimestamp":1734384753,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"** GoodRX    shares rise 1.3% to $4.65 after the bell   ** Co appoints Wendy Barnes as president and chief executive officer effective January 1, 2025   ** Barnes previously held the position of CEO at RxBenefits    ** As CEO, Wendy will focus on bringing all brand affordability programs onto the GoodRx platform, expanding GoodRx's product experience with healthcare professionals and enriching partnerships with retail pharmacies, insurers and pharmaceutical manufacturers - GDRX   ** Barnes replaces Scott Wagner, who was the interim CEO at the company, appointed in April 2023   ** 9 of 18 brokerages rate the stock \"buy\" or higher, 8 \"hold\" and 1 \"sell\"; their median PT is $7   ** YTD, GDRX down 31.4% ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4161":"工业机械","B":"巴恩斯","GDRX":"GoodRx Holdings, Inc."},"translate_title":"BUZZ-GoodRX任命Wendy Barnes为首席执行官；股价上涨","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"B":1,"GDRX":0.9},"content_text":"** GoodRX    shares rise 1.3% to $4.65 after the bell   ** Co appoints Wendy Barnes as president and chief executive officer effective January 1, 2025   ** Barnes previously held the position of CEO at RxBenefits    ** As CEO, Wendy will focus on bringing all brand affordability programs onto the GoodRx platform, expanding GoodRx's product experience with healthcare professionals and enriching partnerships with retail pharmacies, insurers and pharmaceutical manufacturers - GDRX   ** Barnes replaces Scott Wagner, who was the interim CEO at the company, appointed in April 2023   ** 9 of 18 brokerages rate the stock \"buy\" or higher, 8 \"hold\" and 1 \"sell\"; their median PT is $7   ** YTD, GDRX down 31.4% (Reporting by Abhinav Parmar in Bengaluru)((Abhinav.parmar@thomsonreuters.com))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"executive","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2492280556"}